High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1756-0500

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia ; volume:13 ; number:1 ; day:11 ; month:7 ; year:2020 ; pages:1-4 ; date:12.2020
BMC Research Notes / Biomed Central ; 13, Heft 1 (11.7.2020), 1-4, 12.2020

Creator: Butsashvili, Maia
Gvinjilia, Lia
Kamkamidze, George
Metreveli, David
Dvali, Shorena
Rukhadze, Tamar
Gamkrelidze, Amiran
Nasrullah, Muazzam
Shadaker, Shaun
Morgan, Juliette
Averhoff, Francisco

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13104-020-05173-4

URN: urn:nbn:de:101:1-2020090919231125998258

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Butsashvili, Maia
Gvinjilia, Lia
Kamkamidze, George
Metreveli, David
Dvali, Shorena
Rukhadze, Tamar
Gamkrelidze, Amiran
Nasrullah, Muazzam
Shadaker, Shaun
Morgan, Juliette
Averhoff, Francisco
SpringerLink (Online service)

Other Objects (12)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Graffiti | Streetart

HCV

Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

HCV resistance

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Graffiti | Streetart

HCV

Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

HCV resistance

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

Graffiti | Streetart

HCV

Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

HCV resistance

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

High sustained viral response among HCV genotype 3 patients with advanced liver fibrosis: real-world data of HCV elimination program in Georgia

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

HCV

Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

HCV resistance

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

HCV

Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

HCV resistance

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV

HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b

Inhibition of HCV 3a genotype entry through Host CD81 and HCV E2 antibodies

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users

HCV

Evaluation of alcohol use behavior among patients cured through HCV elimination program in Georgia

HCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes

Guidelines Have a Key Role in Driving HCV Elimination by Advocating for Simple HCV Care Pathways

HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a

HCV resistance

Occult HCV or delayed viral clearance from lymphocytes of Chronic HCV genotype 3 patients after interferon therapy

NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b

Effect of combined siRNA of HCV E2 gene and HCV receptors against HCV

Related objects

Reset password